|
|
... each other; they're going to be on separate continents.
Research scientists in the drug business are going through what may be their worst and most uncertain period ever. It would be easy to blame greedy ... much money to discover the ones that we have. Until we find a way out of that impasse -- and speed the day -- drug companies are going to reach for whatever low-cost solutions come to hand. ...
|
|
... traded more than 8% higher on the day. This drug is extremely important to the Vertex pipeline of drugs ... impact on current fundamentals) this does illuminate what the future of these companies will look like. It is extremely difficult to predict the outcome ... HGSI and VRTX just went through, but for some investors this is a risk worth taking.
Innovative Drug Companies Headline the Gainers ...
|
|
... so well? Are they a case for heavy shorting now? Perhaps our favourite straddles our the best way to play them.
These drug companies certainly are capable of doing very effective marketing. In fact, these companies spend more in marketing than in R&D! Clearly, there is something wrong with this picture.
Here are the current performance charts:
...
|
|
... share of voice" among pharmaceutical companies online? While some drug companies have been reluctant to embrace social ... embracing social networks to help brand and position their companies in a positive light with consumers and practitioners. Here are the TOP ... Twitterverse. This definitely puts Bayer at a disadvantage compared to the transparency of other Pharma companies on this TOP TEN list ...
|
|
... based on sickness. The sicker you are, the more drugs you will buy.
In addition, insurance companies, working hand in hand with the AMA and the drug companies, refuse to provide coverage for the wellness approach. Most won ... health care, big pharma is lobbying hard to get the Food and Drug Administration to make many natural supplements available only by prescriptions issued by ...
|
|
Much like the credit card industry is raising interest rates before the Credit Card Act 2009 goes into effect and changes things, prescription drug are dramatically raising prescription drug prices before the health care reform bill makes it through the Senate. It’s a shady business, especially when these exact same drug companies made a promise
|
|
Related Tags
|